These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22486062)
41. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. McCarley PB; Arjomand M Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764 [TBL] [Abstract][Full Text] [Related]
43. Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: implications for kidney patients. Dusilová-Sulková S J Ren Care; 2009 Mar; 35 Suppl 1():39-44. PubMed ID: 19222730 [TBL] [Abstract][Full Text] [Related]
44. [Therapeutic indications obtained from short- and medium-term biohumoral changes after parathyroidectomy]. Sforzini S; Viganò MR; Rosa M; Redaelli B Minerva Med; 1985 Mar; 76(9-10):393-6. PubMed ID: 3982696 [No Abstract] [Full Text] [Related]
45. Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion. Kovesdy CP; Mehrotra R; Kalantar-Zadeh K Clin J Am Soc Nephrol; 2008 Jan; 3(1):168-73. PubMed ID: 18045858 [TBL] [Abstract][Full Text] [Related]
46. Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Hruska KA; Saab G; Mathew S; Lund R Semin Dial; 2007; 20(4):309-15. PubMed ID: 17635820 [TBL] [Abstract][Full Text] [Related]
47. Prevention of renal osteodystrophy. Baker LR Miner Electrolyte Metab; 1991; 17(4):240-9. PubMed ID: 1813786 [TBL] [Abstract][Full Text] [Related]
53. Prevention of metabolic bone disease in the pre-end-stage renal disease setting. Coburn JW; Elangovan L J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772 [TBL] [Abstract][Full Text] [Related]
54. [Role of vitamin D in the pathogenesis of renal osteodystrophy]. Nakanishi S; Fukagawa M Clin Calcium; 2004 Sep; 14(9):15-20. PubMed ID: 15577104 [TBL] [Abstract][Full Text] [Related]
55. [Physiopathology and therapy of renal osteodystrophy and secondary hyperparathyroidism]. Fukagawa M Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1245-50. PubMed ID: 10465972 [No Abstract] [Full Text] [Related]
56. The need to treat predialysis patients. Hamdy NA Nephrol Dial Transplant; 1995; 10 Suppl 4():19-22; discussion 37-43. PubMed ID: 7478145 [No Abstract] [Full Text] [Related]
57. [Etiology and pathology of metabolic bone diseases: renal osteodystrophy]. Shigematsu T; Ogura Y Nihon Rinsho; 1986 Nov; 44(11):2428-36. PubMed ID: 3546796 [No Abstract] [Full Text] [Related]
58. Long term results of subtotal parathyroidectomy in patients with end-stage renal disease. Kim HC; Cheigh JS; David DS; Stubenbord W; Sullivan J; Rubin AL; Stenzel KH Am Surg; 1994 Sep; 60(9):641-9. PubMed ID: 8060033 [TBL] [Abstract][Full Text] [Related]